These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 10760753

  • 1. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients.
    Chak A, Canto MI, Cooper GS, Isenberg G, Willis J, Levitan N, Clayman J, Forastiere A, Heath E, Sivak MV.
    Cancer; 2000 Apr 15; 88(8):1788-95. PubMed ID: 10760753
    [Abstract] [Full Text] [Related]

  • 2. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
    Griffin JM, Reed CE, Denlinger CE.
    Ann Thorac Surg; 2012 Jun 15; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
    [Abstract] [Full Text] [Related]

  • 3. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Ann Thorac Surg; 2004 Oct 15; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [Abstract] [Full Text] [Related]

  • 4. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ, Ceppa D, Okereke I, Rieger KM, Jalal SI, LeBlanc JK, DeWitt JM, Kesler KA, Birdas TJ.
    Ann Surg Oncol; 2014 Nov 15; 21(12):3739-43. PubMed ID: 25047477
    [Abstract] [Full Text] [Related]

  • 5. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.
    Isenberg G, Chak A, Canto MI, Levitan N, Clayman J, Pollack BJ, Sivak MV.
    Gastrointest Endosc; 1998 Aug 15; 48(2):158-63. PubMed ID: 9717781
    [Abstract] [Full Text] [Related]

  • 6. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma.
    Mallery S, DeCamp M, Bueno R, Mentzer SJ, Sugarbaker DJ, Swanson SJ, Van Dam J.
    Cancer; 1999 Sep 01; 86(5):764-9. PubMed ID: 10463973
    [Abstract] [Full Text] [Related]

  • 7. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy.
    Mesenas S, Vu C, McStay M, Forshaw M, Doig L, Mason R, Boyle N, Meenan J.
    Dis Esophagus; 2008 Sep 01; 21(1):37-42. PubMed ID: 18197937
    [Abstract] [Full Text] [Related]

  • 8. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.
    Eloubeidi MA, Wallace MB.
    Gastrointest Endosc; 2001 Jul 01; 54(1):132-4. PubMed ID: 11447984
    [No Abstract] [Full Text] [Related]

  • 9. Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02).
    Jost C, Binek J, Schuller JC, Bauerfeind P, Metzger U, Werth B, Knuchel J, Frossard JL, Bertschinger P, Brauchli P, Meyenberger C, Ruhstaller T.
    Gastrointest Endosc; 2010 Jun 01; 71(7):1114-21. PubMed ID: 20304399
    [Abstract] [Full Text] [Related]

  • 10. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy.
    Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB.
    Am Surg; 2000 Sep 01; 66(9):827-31. PubMed ID: 10993609
    [Abstract] [Full Text] [Related]

  • 11. Prediction of survival by tumor area on endosonography after definitive chemoradiotherapy for locally advanced squamous cell carcinoma of the esophagus.
    Shim CN, Song MK, Lee HS, Chung H, Lee H, Shin SK, Lee SK, Lee YC, Park JC.
    Digestion; 2014 Sep 01; 90(2):98-107. PubMed ID: 25196528
    [Abstract] [Full Text] [Related]

  • 12. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy.
    Kalha I, Kaw M, Fukami N, Patel M, Singh S, Gagneja H, Cohen D, Morris J.
    Cancer; 2004 Sep 01; 101(5):940-7. PubMed ID: 15329901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does neoadjuvant chemoradiation downstage esophageal carcinoma?
    Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW.
    Am J Surg; 2001 May 01; 181(5):440-4. PubMed ID: 11448438
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.
    Zuccaro G, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, Gitlin L, Adelstein DJ.
    Am J Gastroenterol; 1999 Apr 01; 94(4):906-12. PubMed ID: 10201455
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma.
    Mariette C, Balon JM, Maunoury V, Taillier G, Van Seuningen I, Triboulet JP.
    Br J Surg; 2003 Nov 01; 90(11):1367-72. PubMed ID: 14598416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
    Blackham AU, Yue B, Almhanna K, Saeed N, Fontaine JP, Hoffe S, Shridhar R, Frakes J, Coppola D, Pimiento JM.
    J Surg Oncol; 2015 Nov 01; 112(6):597-602. PubMed ID: 26394724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.